Evidence map›Paper›PMID 39271172›Full record

ReviewNutrition reviews2025

The Therapeutic Potential of Theobromine in Obesity: A Comprehensive Review.

Dilem Tuğal Aslan, Zeynep Göktaş

Abstract readReview
In one paragraph

Review in Nutrition reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dilem Tuğal AslanDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Altindag, Ankara, Turkiye.ORCID 0000-0003-1761-1919
Zeynep GöktaşDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Altindag, Ankara, Turkiye.ORCID 0000-0001-7241-8017

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity, characterized by chronic low-grade inflammation, is a significant health concern. Phytochemicals found in plants are being explored for therapeutic use, particularly in combating obesity. Among these, theobromine, commonly found in cocoa and chocolate, shows promise. Although not as extensively studied as caffeine, theobromine exhibits positive effects on human health. It improves lipid profiles, aids in asthma treatment, lowers blood pressure, regulates gut microbiota, reduces tumor formation, moderates blood glucose levels, and acts as a neuroprotective agent. Studies demonstrate its anti-obesity effects through mechanisms such as browning of white adipose tissue, activation of brown adipose tissue, anti-inflammatory properties, and reduction of oxidative stress. This study aims to suggest theobromine as a potential therapeutic agent against obesity-related complications.

Indexed as

Anti-Obesity AgentsObesityTheobromineAnimalsAnti-Inflammatory AgentsGastrointestinal MicrobiomeHumansOxidative StressAnti-Inflammatory AgentsAnti-Obesity AgentsTheobromineanti-inflammatoryantioxidantbrowningobesitytheobromine

Identifiers

PMID39271172
PMCPMC11986327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.